# FDA Inspection 1252745 - Actelion Pharmaceuticals US Inc. - October 28, 2024

Source: https://www.keypedia.com/records/fda_inspections/actelion-pharmaceuticals-us-inc/42933576-b78e-47aa-9776-8c1f99b939b9
Source feed: FDA_Inspections

> FDA Inspection 1252745 for Actelion Pharmaceuticals US Inc. on October 28, 2024. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1252745
- Company Name: Actelion Pharmaceuticals US Inc.
- Inspection Date: 2024-10-28
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Postmarketing Surveillance and Epidemiology: Human Drugs
- Product Type: Human Drugs
- Office Name: New Jersey District Office

## Related Documents

- [FDA Inspection 1252745 - 2024-10-28](https://www.keypedia.com/records/fda_inspections/actelion-pharmaceuticals-us-inc/be6c3f37-5375-4dc0-ab96-f2409d61b246)

Company: https://www.keypedia.com/companies/actelion-pharmaceuticals-us-inc/dcd7e330-a940-41bf-bf05-d121684e4612

Office: https://www.keypedia.com/offices/new-jersey-district-office/6ff5e2e9-5cff-44c7-af24-5a55329a8248